封面
市場調查報告書
商品編碼
2039093

介入性心臟病設備市場:按設備、最終用戶和地區分類

Interventional Cardiology Devices Market, By Device, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2026 年,介入性心臟病設備市場規模將達到 426.031 億美元,到 2033 年將達到 701.711 億美元。預計從 2026 年到 2033 年,該市場將以 7.5% 的複合年成長率成長。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 426.031億美元
歷史數據時期: 2020-2024 預測期: 2026-2033
2026年至2033年預測期間的複合年成長率: 7.50% 2033年市場規模預測: 701.711億美元

介入性心臟病學是循環系統的一個分支,專門從事基於導管的心臟疾病治療,例如先天性心臟疾病(CHD)、冠狀動脈疾病和動脈瘤。此手術包括將導管插入股動脈或其他較大的周邊動脈和靜脈,並在透視引導下完成整個導管介入手術。介入性心臟病學透過促進患者快速康復、縮短住院時間和控制出血,從而減少併發症。介入性心臟病學的器械也在不斷發展,從裸金屬支架到生物可吸收支架。根據美國疾病管制與預防中心(CDC)統計,2016年約有4萬名嬰兒出生時患有先天性心臟疾病(CHD)。美國疾病管制與預防中心提供各種疾病的資訊。介入性心臟病學的器械包括導管、導管導引線、支架、濾器和球囊。

影響全球介入性心臟病設備市場的因素。

預測期內阻礙介入性心臟病設備市場成長的主要因素是高成本。

本研究的關鍵特徵

  • 本研究確定了各個細分市場的潛在商機,並說明了該市場具有吸引力的投資提案矩陣。
  • 此外,本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、區域前景以及主要參與者採取的競爭策略。
  • 本研究根據以下參數對全球介入性心臟病設備市場的主要參與者進行了分析:公司概況、財務績效、產品系列、企業發展區域、分銷策略、主要發展、策略和未來計劃。
  • 透過利用本報告中的見解,企業行銷負責人和經營團隊將能夠就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
  • 全球介入性心臟病設備市場報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等產業相關人員。
  • 相關人員可以透過利用市場分析中使用的各種策略矩陣來簡化決策過程。

目錄

第1章:研究目標與假設

  • 研究目標
  • 前提
  • 簡稱

第2章 市場範圍

  • 報告摘要
    • 市場定義和範圍
  • 執行摘要
  • 一致性機會圖(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因子
    • 市場機遇
  • 影響分析
  • 法規環境
  • PEST分析

第4章 全球介入性心臟病設備市場:依設備類型分類,2021-2033年

  • 血管造影術導管
  • IVUS
  • PTCA導管導引線
  • 引導管
  • 氣球膨脹裝置
  • 支架

第5章 全球介入性心臟病設備市場:依最終用戶分類,2021-2033年

  • 醫院
  • 診所
  • 門診手術中心

第6章 全球介入性心臟病設備市場:依地區分類,2021-2033年

  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中東
  • GCC
  • 以色列
  • 其他中東國家
  • 非洲
  • 北非
  • 中非
  • 南非

第7章 競爭情勢

  • 公司簡介
    • Abbott Laboratories
    • Terumo Medical Corporation
    • Boston Scientific Corporation
    • Cardinal Health
    • Medtronic Plc
    • Cook Medical
    • SINOMED
    • BioTronik SE & Co. KG
    • B. Braun Melsungen AG

第8章

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI691

Interventional Cardiology Devices Market is estimated to be valued at USD 42,603.1 Mn in 2026 and is expected to reach USD 70,171.1 Mn by 2033, growing at a compound annual growth rate (CAGR) of 7.5% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 42,603.1 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 7.50% 2033 Value Projection: USD 70,171.1 Mn

Interventional cardiology is the branch of cardiology that specifically deals with catheter based treatment of heart diseases, such as congenital heart defect (CHD), coronary artery disease, and aneurysm. This involves insertion of the catheter into femoral artery or any large peripheral artery or vein and through catheter whole procedure is performed by using fluoroscopy. Interventional cardiology has reduced the complications for patients as it provides, fast recovery, short hospital stay, and controlled bleeding. There is constant development in interventional cardiology devices, such as from bare metal stent to bio-absorbable stent. According to Centers for Disease Control and Prevention, which provides information about various diseases, there were around 40,000 children born with CHD in the U.S. in 2016. Interventional cardiology devices include catheters, guide wire, stents, filters, and balloons.

Restraints of the Global Interventional Cardiology Devices Market

Major factors hampering the growth of the interventional cardiology devices market during the forecast period constitutes of high costs

Key features of the study

  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global interventional cardiology devices market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Abbott Laboratories, Terumo Medical Corporation, Boston Scientific Corporation, Cardinal Health, Medtronic, Cook Medical, SINOMED, Biotronik SE & Co. KG, and B. Braun Melsungen AG.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global interventional cardiology devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Market Segmentation

  • By Device (Revenue, USD Mn, 2021 - 2033)
    • Angiography Catheters
    • IVUS
    • PTCA Guidewires
    • Guiding Catheters
    • Balloon Inflation Devices
    • Stents
  • By End User Insights (Revenue, USD Mn, 2021 - 2033)
    • Hospitals
    • Clinics
    • Ambulatory Surgical Centers
  • By Region Insights (Revenue, USD Mn, 2021 - 2033)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East & Africa
    • GCC Countries
    • Israel
    • Rest of Middle East & Africa
  • Key Players
    • Abbott Laboratories
    • Terumo Medical Corporation
    • Boston Scientific Corporation
    • Cardinal Health, Medtronic
    • Cook Medical
    • SINOMED
    • Biotronik SE & Co. KG
    • B. Braun Melsungen AG

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Device
    • Market Snippet, By End User
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • PEST Analysis

4. Global Interventional Cardiology Devices Market, By Device, 2021 - 2033 (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021-2033
    • Segment Trends
  • Angiography Catheters
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  • IVUS
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  • PTCA Guidewires
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  • Guiding Catheters
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  • Balloon Inflation Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  • Stents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

5. Global Interventional Cardiology Devices Market, By End User, 2021 - 2033 (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021-2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

6. Global Interventional Cardiology Devices Market, By Regions, 2021 - 2033 (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2021-2033
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  • North Africa
  • Central Africa
  • South Africa

7. Competitive Landscape

  • Company Profiles
    • Abbott Laboratories
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Terumo Medical Corporation
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Boston Scientific Corporation
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Cardinal Health
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Medtronic Plc
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Cook Medical
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • SINOMED
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Biotronik SE & Co. KG
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • B. Braun Melsungen AG
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies

8. Section

  • References
  • Research Methodology
  • About us and Sales Contact